bullish
Suzhou Basecare Medical IPO: First Mover with the Only NMPA-Approved PGT Product in China
360 Views27 Jan 2021 03:17
The Chinese genetic testing solutions provider for assisted reproduction, Suzhou Basecare Medical has filed for an IPO to list its shares on the Hong Kong Stock Exchange.
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 8-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Apple: 1Q FY09/21 Earnings Set New All-Time Records28 Jan 2021
- CyberAgent: Game Business Continues to Disappoint but Internet Ad and ABEMA Performs Steadily28 Jan 2021
- Suzhou Basecare Medical IPO Valuation: Attractive Even at the Upper End of the IPO Pricing28 Jan 2021
- Kuaishou IPO Valuation: Attractive Valuation25 Jan 2021
- JD Health IPO Trading Update: Be Ready to Buy if It Drops Post Index Inclusion21 Dec 2020
- Hygeia Healthcare IPO (Part I): A Better Healthcare16 Jun 2020
x